aviation-on-the-brink-expert-explains-why-replacing-the-soviet-fleet-is-currently-impossible

Aviation on the brink: expert explains why replacing the “Soviet fleet” is currently impossible

 • 295781 переглядiв

After the start of the full-scale invasion of Russia, the Ukrainian aviation industry was on the verge of survival. Civil aviation has practically stopped, and aviation enterprises have been hit by the loss of access to critical components of Soviet and Russian origin, which cannot be quickly replaced, for example, with components of their own production. At the same time, this industry remains key to Ukraine's defense capability.

UNN spoke with Ruslan Melnychenko, head of the legal committee of the Aerospace Association of Ukraine and lawyer, about the real state of aviation in the context of the war, legal risks for business, blocking critical supplies due to the inconsistency of regulators, and why the issue of using Soviet equipment is not a choice, but a forced step.

– How has the state of the Ukrainian aviation industry changed since the beginning of the full-scale war?

First of all, it should be understood that we have lost an entire industry in its pre-war form. The civil aviation industry has suffered extremely heavy losses, which is due, in particular, to the impossibility of civil aircraft flying in the airspace of Ukraine. Companies that focused on the domestic market or flights to/from Ukraine have been virtually destroyed. Only those who managed to reformat themselves for international contracts or military logistics remained.

But at the same time, the aviation infrastructure — airfields, repair plants, technical bases — is preserved and even partially functioning. And it is critical, because aviation today is part of defense capability. This includes not only combat helicopters, but also medical evacuation, transportation, and humanitarian logistics.

– What is the fate of the Soviet air fleet, which is still actively used?

As of now, Ukraine operates more than 300 units of military and more than 200 units of civil aviation equipment of Soviet origin. These are Mi-8, Mi-17 helicopters, Antonov aircraft — everything that has been preserved since the USSR. That is, today 90% of the available aircraft are of Soviet origin, and the infrastructure for their maintenance has been formed over decades.

Ukraine has a unique system for supporting the operation of Soviet aircraft and has the potential to become an alternative center for their maintenance.

We have a historically unique infrastructure for their maintenance — this is our strength. However, the problem is different: these machines need parts, repair documentation, technical support. And most of this is either of Russian origin or was once supplied from Russia.

Today we are dealing with a paradox: the equipment is still suitable, there are specialists, the infrastructure is working, but there are no parts. Or — there are, but they are under sanction risk.

If the Ukrainian aviation industry does not reach a common decision on the further operation of Soviet-era aircraft designed in Russia, the operation of these types of aircraft will be completely stopped. In fact, this will mean the loss of the Ukrainian aviation school, which has Soviet approval. Ukraine's transition to Western technology with the abandonment of the operation of Soviet-designed aircraft will completely stop the domestic aviation industry. 

The state should officially allow Ukrainian enterprises, until they are replaced by domestic or Western analogues, to import from abroad, except for the aggressor state, components, spare parts and consumables, developed by the former USSR or Russia, provided that such components were manufactured before the full-scale invasion of Ukraine. Otherwise, Ukraine will lose its status as one of the leading aviation countries in the world.

In addition, Russia is actively spreading disinformation about the "malfunction" or "danger" of Ukrainian aviation in order to undermine confidence in it among international partners and potential investors. In addition, the aggressor state can use its influence in organizations such as ICAO, the UN to deny certain certifications, question safety standards or try to introduce restrictions for Ukrainian aviation. It may also try to discredit Ukrainian import substitution efforts by spreading rumors about the use of counterfeit or uncertified spare parts. This creates additional pressure and requires Ukraine to maintain extremely strict quality control.

– How is the industry trying to survive in such conditions?

This is a real struggle for survival. Parts are searched for literally all over the world: in Poland, Bulgaria, Slovakia, even in Latin America. These are old stocks, often manufactured before 2014 or even before 1991. They are usually purchased from warehouses in several stages, without the Russian element, in order not to fall under sanctions or financial monitoring.

The problem is not only with the purchases themselves, but also with the fact that Ukraine often has an overly formalized approach: customs sees the marking "made in USSR" or "Russia" — and blocks the cargo. Although this product has been in circulation in EU countries for decades and has nothing to do with supporting the aggressor.

– This sounds like a direct threat to the functioning of the industry. Why is this not being resolved at the state level?

There are several reasons. First, fear. Both among officials and entrepreneurs. Because any step can be interpreted as "cooperation with Russia." Second, legal uncertainty. Our legislation does not have clear criteria for what constitutes "economic ties with the aggressor." Because of this, many companies are simply afraid to act — because they do not want to become an object of pressure.

Third, a lack of understanding at the level of society. For many citizens, unfortunately, the word "Russian part" is unambiguous. But the problem is deeper: either we use these parts from third countries, or we stop all aviation. And then it is no longer a question of morality, but a question of life and death — literally.

– What risks do companies that still continue to operate in such conditions face?

There is a risk of criminal prosecution — for example, under the articles of the Criminal Code on collaborationism or treason. Especially if law enforcement officers decide to interpret the supply of parts with the "wrong" marking as cooperation with Russia. Add to this information pressure, "black PR", commissioned media campaigns — and you get a picture in which it becomes almost impossible to work honestly and transparently.

At the same time, the state itself depends on this industry: military aviation is served by the same enterprises that are working on the verge of survival. If they are stopped tomorrow — who will repair the helicopters of the Armed Forces?

– Is import substitution of Soviet components realistic in the short term?

No. We do not have a full production cycle. We never did. The most critical components — electronics, navigation, composite materials — were manufactured in Russia. Replacing them means creating new technologies from scratch, undergoing certification, and developing technical regulations. This is 5–10 years and billions in investment.

The only thing that is realistic now is partial import substitution where possible, and legalization of purchases of what already exists in the world. Especially — in the warehouses of NATO countries, which themselves once operated Soviet equipment.

It is worth noting that the economic efficiency of operating, for example, Soviet-made helicopters demonstrates extremely high profitability. The average service life after overhaul is on average 8-10 years, while maintenance is almost completely provided by domestic components.

The structure of expenses and revenues shows impressive economic efficiency: with moderate expenses for maintenance and overhaul, the industry generates significant foreign exchange earnings. More than half of the cost of overhaul is work performed by Ukrainian enterprises.

– What solutions could stabilize the situation?

At a minimum, we need:

1. Legally allow the import of Soviet components manufactured before 2022 from third countries.

2. Provide legal guarantees for enterprises operating in the industry — so that they are not pressured on trumped-up charges.

3. Restore tax benefits that were abolished from 2025, in particular — for aircraft construction and repair enterprises.

4. Launch a targeted state program to modernize aviation infrastructure and develop critical technologies.

5. Explain to the public that the use of such parts is not collaboration, but the only way to avoid destroying Ukrainian aviation.

– What role does the Aerospace Association of Ukraine play in all of this?

The Association is a communication platform. We unite more than 35 enterprises — from airlines to manufacturers and design bureaus. Our task is to coordinate actions, promote the interests of the industry, work with the state and convey the real state of affairs to international partners. Because even at the level of ministries, there is no understanding of how critical the situation is.

– Is Russia really trying to block the modernization of our air fleet?

Yes. There are cases when Russia, through its structures, bought up parts in third countries that could have reached Ukraine. This is a struggle at the level of logistics routes, sanctions, access to documentation. And it is very aggressive.

Our ability to lift a helicopter into the air is not a symbol, it is a factor that directly affects the course of the war.

In addition, the export of aviation services is a direct investment in the Ukrainian economy. That is why it is no secret that Russia is actively working to minimize the supply of any, and especially critical (non-import-substitutable) Russian components for Ukrainian aviation.

– What will happen if the state does not change its policy in its approaches to regulating the aviation industry?

We will lose this industry. And we will lose not only equipment, but also people. Engineers, pilots, mechanics — will leave the profession or go abroad. We will no longer be able to restore production, we will lose export contracts, we will lose the war at the level of technology. And we will also be left without defense aviation.

Today, the question is stark: either we make a balanced decision and save the industry, or in 2–3 years there will be nothing left to save.

In the face of Russian aggression, Ukraine cannot allow a protracted systemic crisis in the aviation industry22.05.25, 17:24 • [views_605542]

Popular

Sleight of hand and no fraud, or how to save the profits of drug manufacturers Фармацевтичний ринок – один з найбільш зарегульованих у світі. З одного боку, це захищає споживачів від неякісної продукції та шахрайства. З іншого боку, зарегульованість може використовуватись і для захисту інтересів великих фармацевтичних компаній. Одним з таких інструментів є патентний захист. Патент дає компанії ексклюзивні права на виробництво та продаж певного лікарського засобу протягом певного періоду часу, зазвичай 20 років. Це дозволяє компанії встановлювати високі ціни на ліки, щоб компенсувати витрати на дослідження та розробку. Після закінчення терміну дії патенту, інші компанії можуть починати виробництво генериків – копій оригінального лікарського засобу. Генерики зазвичай дешевші за оригінальні ліки, що робить їх доступнішими для споживачів. Однак, фармацевтичні компанії часто використовують різні стратегії, щоб продовжити термін дії патентного захисту своїх ліків. Однією з таких стратегій є подання нових патентів на незначні зміни в лікарському засобі, такі як зміна форми випуску або дозування. Так зване «вічнозелене патентування». Це дозволяє компанії продовжувати отримувати високі прибутки від продажу ліків, навіть після закінчення терміну дії оригінального патенту. Іншою стратегією є укладання угод з виробниками генериків, щоб ті не випускали генерики на ринок. Так звані «pay-for-delay» угоди. Фармацевтична компанія платить виробнику генериків, щоб той відклав випуск генерика на певний період часу. Такі угоди є незаконними в багатьох країнах, але вони все ще зустрічаються на практиці. Обидві ці стратегії призводять до того, що споживачі змушені переплачувати за ліки. В Україні, як і в багатьох інших країнах, патентний захист фармацевтичної продукції є досить суворим. Це з одного боку стимулює інновації, але з іншого боку робить ліки менш доступними для населення. Для вирішення цієї проблеми, необхідно збалансувати інтереси фармацевтичних компаній та споживачів. З одного боку, необхідно забезпечити компаніям можливість отримувати прибуток від своїх інновацій. З іншого боку, необхідно зробити ліки більш доступними для населення. Одним з можливих рішень є посилення контролю за видачею патентів на фармацевтичну продукцію. Патентні відомства повинні більш ретельно перевіряти, чи є заявлені зміни в лікарському засобі дійсно інноваційними, чи вони є лише спробою продовжити термін дії патентного захисту. Іншим можливим рішенням є посилення контролю за укладанням угод між фармацевтичними компаніями та виробниками генериків. Антимонопольні органи повинні більш ретельно розслідувати такі угоди, щоб запобігти зловживанням. Крім того, необхідно розвивати виробництво генериків в Україні. Це дозволить знизити ціни на ліки та зробити їх більш доступними для населення. В цілому, для вирішення проблеми доступності ліків в Україні, необхідний комплексний підхід, який включає в себе посилення контролю за патентним захистом, боротьбу зі зловживаннями на фармацевтичному ринку та розвиток виробництва генериків. The pharmaceutical market is one of the most regulated in the world. On the one hand, this protects consumers from substandard products and fraud. On the other hand, regulation can also be used to protect the interests of large pharmaceutical companies. One such tool is patent protection. A patent gives a company exclusive rights to manufacture and sell a particular drug for a certain period of time, usually 20 years. This allows the company to set high prices for the drug to recoup its research and development costs. After the patent expires, other companies can begin producing generics – copies of the original drug. Generics are usually cheaper than original drugs, making them more accessible to consumers. However, pharmaceutical companies often use various strategies to extend the term of patent protection for their drugs. One such strategy is to file new patents on minor changes to the drug, such as changing the dosage form or dosage. This is so-called "evergreening." This allows the company to continue to generate high profits from the sale of the drug, even after the original patent expires. Another strategy is to make agreements with generic manufacturers not to release generics to the market. These are so-called "pay-for-delay" agreements. The pharmaceutical company pays the generic manufacturer to delay the release of the generic for a certain period of time. Such agreements are illegal in many countries, but they still occur in practice. Both of these strategies result in consumers being forced to overpay for medicines. In Ukraine, as in many other countries, patent protection for pharmaceutical products is quite strict. On the one hand, this encourages innovation, but on the other hand, it makes medicines less accessible to the population. To solve this problem, it is necessary to balance the interests of pharmaceutical companies and consumers. On the one hand, it is necessary to ensure that companies can profit from their innovations. On the other hand, it is necessary to make medicines more accessible to the population. One possible solution is to strengthen control over the issuance of patents for pharmaceutical products. Patent offices should more thoroughly check whether the claimed changes in the drug are truly innovative, or whether they are just an attempt to extend the term of patent protection. Another possible solution is to strengthen control over the conclusion of agreements between pharmaceutical companies and generic manufacturers. Antimonopoly authorities should more thoroughly investigate such agreements to prevent abuses. In addition, it is necessary to develop the production of generics in Ukraine. This will reduce the prices of medicines and make them more accessible to the population. In general, to solve the problem of access to medicines in Ukraine, a comprehensive approach is needed, which includes strengthening control over patent protection, combating abuses in the pharmaceutical market, and developing the production of generics.

 • 12422 переглядiв

Elon Musk said he regrets some of his posts about Trump

 • 41677 переглядiв

NATO seeks to include funds for Ukraine in new spending target - Bloomberg

 • 35319 переглядiв

News by theme

OSZAR »
OSZAR »